Previous 10 |
National Research (NYSE: NRC ) declares $0.17/share quarterly dividend , in line with previous. More news on: National Research Corporation, Dividend News, Read more ...
Lincoln, Nebraska, Sept. 04, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 (seventeen cents) per share payable Monday, October 15, 2018, to shareholders of record as of the clos...
SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- The Marriott Marquis in San Diego played host to a unique event in the healthcare industry. Starting on August 26 th , NRC Health’s Symposium for Inspiring Loyalty drew attendees from every discipline in the field, bringing them together...
SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Kaiser Permanente Woodland Hills Medical Center of Woodland Hills, California, was recognized as the winner of the 2018 Improvement Best Practice Award at the 24 th Annual NRC Health Symposium in San Diego, California, on Sunday, August 26. T...
LINCOLN, Neb., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of in-depth customer intelligence in healthcare, today announced the winners of its 2017-2018 NRC Health Consumer Loyalty Awards . The Consumer Loyalty Awards are the first, and only loyalty-based hospital ...
News, Short Squeeze, Breakout and More Instantly...
National Research Corporation Company Name:
NRC Stock Symbol:
NASDAQ Market:
National Research Corporation Website:
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is partnering with non-profit This Is My Bra...
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team wil...
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it entered into a debt ...